Curis, Inc. (CRIS) vs Propanc Biopharma Inc (PPCB)
Curis, Inc. and Propanc Biopharma Inc are both Biotechnology companies. Propanc Biopharma Inc is the larger, with a market value of $2.1M against $1.8M — 1.2× the size. Curis, Inc. has negative trailing earnings, so its P/E is not meaningful; Propanc Biopharma Inc trades at 0.0×. Across the 10 metrics below, Propanc Biopharma Inc leads on 6 and Curis, Inc. on 4.
Valuation
Profitability
| Metric | CRIS | PPCB | Biotechnology median |
|---|---|---|---|
| Gross margin | 99.52% | — | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 455.35% | (138.20%) | (57.72%) |
| Return on assets | (87.76%) | (104.68%) | (49.22%) |
| Return on invested capital | 0.00% | (116.59%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack